Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on December 2025 ACIP Meeting
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
Learn more
BIO Statement on the Retirement of Richard Pazdur…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…
Learn more
BIO Statement on House Passage of Mikaela Naylon…
WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Announces Beth Ellikidis as Vice President, Agriculture and Environment
November 14, 2022
The Biotechnology Innovation Organization (BIO) is pleased to announce that Beth Ellikidis has joined BIO as Vice President, Agriculture and Environment. In her role, Beth will lead the policy and market access strategies for BIO’s Agriculture and…
BIO Announces 2022 Impact Awards
November 3, 2022
Awards Recognize Innovators in Agricultural, Environmental and Industrial Biotechnology   The Biotechnology Innovation Organization today announced Dr. Annie Tsong, chief strategy & product officer at Amyris, as the winner of this year’s…
BIO: Mexico's Biotech Corn Ban Will Cause Food Security Crisis
October 28, 2022
Washington, D.C. (October 28, 2022) – BIO is disappointed to hear Mexico intends to proceed with its plan to arbitrarily restrict imports of biotech corn. While Mexico states that Brazil, Argentina, and other countries may appear to be alternative…
Biotech Sector Thrives, Generating Nearly $3 Trillion Economic Impact – New Report Shows
October 26, 2022
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States.The new report, The U.S. Bioscience Industry: Fostering Innovation and…
BIO encourages Administration to "bring transparency to the broken rebate system"
October 14, 2022
After the White House announced plans to sign an Executive Order directing the Department of Health and Human Services (HHS)  to explore additional actions to lower prescription drug costs, Nick Shipley, Chief Advocacy Officer at the…
Established Industry Leader Rachel King will Serve as BIO’s Interim Leader
October 10, 2022
 The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to…
BIO Announces Leadership Update
October 10, 2022
Today, Dr. Michelle McMurry-Heath informed the Biotechnology Innovation Organization (BIO) Executive Committee that she is stepping down from her position as President and Chief Executive Officer effective October 11, 2022, and she has agreed to…
Implications and Consumer Price Impacts of Mexico's Biotech Corn Ban
October 3, 2022
Washington, D.C. (October 3, 2022) – Today, a coalition of leading food and agriculture industry stakeholders in both Mexico and the United States released a new study revealing the broad impacts of Mexico’s proposed ban on biotech corn. The report,…
Announcement of PDUFA Agreement in Congress Supports Biomedical Innovation, Helps Patients
September 22, 2022
Biotechnology Industry Organization (BIO) President and CEO, Dr. Michelle McMurry-Heath, released the following statement following the announcement that Congress reached an agreement on the Prescription Drug User Fee Act (PDUFA): “For 30…
Biden's Executive Order to Advance Biotechnology, Biomanufacturing Prioritizes Science to Solve Global Challenges
September 12, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization, released the following statement in response to the Biden Administration’s “Advancing Biotechnology and Biomanufacturing” Executive Order: “BIO welcomes…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today